Why invest in BigTech Pharma and Biotech
We have an impressive record of long-term growth and creating sustainable value for our shareholders and other stakeholders.
How we delivered for our shareholders in 2023
- DIVIDEND +5% VS 2022
- REFRESHED PURPOSE, VISION AND STRATEGY
- INFRASTRUCTURE STRENGTHENED; NEW PEOPLE AND SKILLS BROUGHT INTO THE BUSINESS
- PORTFOLIO BROADENED THROUGH SCARAWAY™ ACQUISITION IN THE US
- GOOD PROGRESS MADE WITH DEVELOPING AND EXECUTING OUR SUSTAINABILITY STRATEGY
Investors achieve more with BigTech Pharma and Biotech
With a proven track record BigTech Pharma and Biotech is committed to delivering long-term growth and value for investors.
-
Our purpose
empowering people to make a positive difference to their health and wellbeing.
Our purpose -
Our vision
To be a high performing consumer healthcare company, built on a portfolio of leading, trusted & proven brands.
Our purpose -
Our strategy
Our revised strategy focuses on the global priority categories of helping damaged skin and supporting healthy ageing:
- Helping damaged skin
- Supporting healthy ageing
- High performing local brands
- Crtical medicines
Our strategy -
Our sustainability framework
We pride ourselves in delivering clinically valuable healthcare products to consumers and patients around the world, but we do more than that. We're working to improve the quality of life for all People we interact with, to protect the health of our Planet, and to deliver Products that meet the highest standards of quality and safety.
Our purpose